Narrow your search

Library

KU Leuven (17)

VDIC (16)

ULB (12)

ULiège (11)

Odisee (10)

LUCA School of Arts (9)

Thomas More Kempen (9)

Thomas More Mechelen (9)

UCLL (9)

VIVES (9)

More...

Resource type

book (31)

periodical (1)


Language

English (29)

French (3)


Year
From To Submit

2009 (32)

Listing 1 - 10 of 32 << page
of 4
>>
Sort by

Book
Health, risk and adversity.
Authors: ---
ISBN: 9781845454555 Year: 2009 Publisher: New York Berghahn

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
State of the USA health indicators : letter report
Authors: --- ---
ISBN: 0309128625 9786612008054 1282008056 0309128633 0309185440 Year: 2009 Publisher: Washington, D.C. : National Academies Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Risk-screening environmental indicators (RSEI)
Author:
Year: 2009 Publisher: [Washington, DC] : U.S. Environmental Protection Agency,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The Risk-Screening Environmental Indicators (RSEI) is a computer-based screening tool developed by EPA that analyzes risk factors to put Toxics Release Inventory (TRI) release data into a chronic health context. RSEI is often used by government regulators, communities, journalists, industry and others.


Book
Letter report on the development of a model for ranking FDA product categories on the basis of health risks
Author:
Year: 2009 Publisher: Washington, D.C. : National Academies Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

In light of the increased use of CRA by federal agencies, the Department of Health and Human Services (DHHS) and the Food and Drug Administration (FDA) asked the National Research Council to convene an expert committee to develop and apply an evidence-based conceptual model and methods for ranking categories of products addressed by FDA programs. The conceptual model and methods were to focus on ranking product categories according to the ranges of magnitude of various potential health consequences to U.S. users of the products at the individual level and the population level, taking both adverse and beneficial effects into consideration. To accomplish its task, the committee was to include the following activities: consult with the sponsor to select FDA product categories to be ranked; consider products currently in use and near-term future products expected to come under FDA purview; review selected scientific literature bearing on adverse and beneficial health consequences; consider the scientific literature broadly to include social-science and economics literature, gray literature, and regulatory-policy literature; seek opportunities to assess health consequences in a way that allows results to be compared among broad product categories; identify information needed to address key uncertainties; assess the performance of the evidence-based model for ranking the selected product categories and identify next steps for model refinement; and where applicable and feasible, consider the potential effects on population health if risk-reduction strategies curtail the beneficial use of products.


Book
Letter report on the development of a model for ranking FDA product categories on the basis of health risks
Author:
Year: 2009 Publisher: Washington, D.C. : National Academies Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

In light of the increased use of CRA by federal agencies, the Department of Health and Human Services (DHHS) and the Food and Drug Administration (FDA) asked the National Research Council to convene an expert committee to develop and apply an evidence-based conceptual model and methods for ranking categories of products addressed by FDA programs. The conceptual model and methods were to focus on ranking product categories according to the ranges of magnitude of various potential health consequences to U.S. users of the products at the individual level and the population level, taking both adverse and beneficial effects into consideration. To accomplish its task, the committee was to include the following activities: consult with the sponsor to select FDA product categories to be ranked; consider products currently in use and near-term future products expected to come under FDA purview; review selected scientific literature bearing on adverse and beneficial health consequences; consider the scientific literature broadly to include social-science and economics literature, gray literature, and regulatory-policy literature; seek opportunities to assess health consequences in a way that allows results to be compared among broad product categories; identify information needed to address key uncertainties; assess the performance of the evidence-based model for ranking the selected product categories and identify next steps for model refinement; and where applicable and feasible, consider the potential effects on population health if risk-reduction strategies curtail the beneficial use of products.


Book
An approach to using toxicogenomic data in U.S. EPA human health risk assessments : a dibutyl phthalate case study.
Author:
Year: 2009 Publisher: Washington, DC : National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Protecting the protectors : ensuring the health and safety of our first responders in the wake of catastrophic disasters : full hearing before the Committee on Homeland Security, House of Representatives, One Hundred Tenth Congress, first session, September 20, 2007.
Author:
Year: 2009 Publisher: Washington : U.S. G.P.O.,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Screening for drug use in general medical settings : quick reference guide.
Author:
Year: 2009 Publisher: [Rockville, Md.] : National Institute on Drug Abuse,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Environmental Health
Author:
ISBN: 0674014944 9780674041189 0674041186 9780674014947 Year: 2009 Publisher: Cambridge, MA

Loading...
Export citation

Choose an application

Bookmark

Abstract

Environmental Health has established itself as the most succinct and comprehensive textbook on the subject. This extensively revised and rewritten third edition continues this tradition by incorporating new developments and by adding timely coverage of topics such as environmental economics and terrorism. As in previous volumes, the new edition presents balanced assessments of environmental problems, examining their local and global implications, their short- and long-range impacts, and their importance in both developed and less developed countries of the world. The Third Edition also addresses emerging issues such as environmental justice, deforestation, the protection of endangered species, multiple chemical sensitivity, and the application of the threshold concept in evaluating the effects of toxic and radioactive materials. Whether discussing acid rain, ozone depletion, global warming, or more traditional subjects such as the management and control of air, water, and food, Dade Moeller emphasizes the need for a systems approach. As with previous volumes, Environmental Health, Third Edition, offers a depth of understanding that is without peer. While it covers technical details, it is also a book that anyone with an interest in the environment can pick up and browse at random.


Book
Peer review of EPA's Risk and Exposure Assessment to Support the Review of the Secondary National Ambient Air Quality Standard (NAAQS) for Oxides of Nitrogen and Sulfur : second draft
Authors: --- ---
Year: 2009 Publisher: Washington, D.C. : U. S. Environmental Protection Agency, Office of the Administrator, Science Advisory Board, Clean Air Scientific Advisory Committee,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Listing 1 - 10 of 32 << page
of 4
>>
Sort by